Tsai PJ - Search Results

1

Advances in the Application of Nanomaterials as Treatments for Bacterial Infectious Diseases.

Hung YP, Chen YF, Tsai PJ, Huang IH, Ko WC, Jan JS. Hung YP, et al. Among authors: tsai pj. Pharmaceutics. 2021 Nov 12;13(11):1913. doi: 10.3390/pharmaceutics13111913. Pharmaceutics. 2021. PMID: 34834328 Free PMC article. Review.

2

Antimicrobial susceptibilities and molecular epidemiology of clinical isolates of Clostridium difficile in taiwan.

Lin YC, Huang YT, Tsai PJ, Lee TF, Lee NY, Liao CH, Lin SY, Ko WC, Hsueh PR. Lin YC, et al. Among authors: tsai pj. Antimicrob Agents Chemother. 2011 Apr;55(4):1701-5. doi: 10.1128/AAC.01440-10. Epub 2011 Jan 24. Antimicrob Agents Chemother. 2011. PMID: 21263053 Free PMC article.

3

Impact of toxigenic Clostridium difficile colonization and infection among hospitalized adults at a district hospital in southern Taiwan.

Hung YP, Tsai PJ, Hung KH, Liu HC, Lee CI, Lin HJ, Wu YH, Wu JJ, Ko WC. Hung YP, et al. Among authors: tsai pj. PLoS One. 2012;7(8):e42415. doi: 10.1371/journal.pone.0042415. Epub 2012 Aug 2. PLoS One. 2012. PMID: 22876321 Free PMC article.

4

Aeromonas aquariorum septicemia and enterocolitis in a cirrhotic patient.

Wu CJ, Tsai PJ, Chen PL, Wu IC, Lin YT, Chen YH, Wang LR, Ko WC. Wu CJ, et al. Among authors: tsai pj. Diagn Microbiol Infect Dis. 2012 Dec;74(4):406-8. doi: 10.1016/j.diagmicrobio.2012.08.005. Epub 2012 Sep 17. Diagn Microbiol Infect Dis. 2012. PMID: 22995364

5

Effects of PPARγ and RBP4 gene variants on metabolic syndrome in HIV-infected patients with anti-retroviral therapy.

Hung YP, Lee NY, Lin SH, Chang HC, Wu CJ, Chang CM, Chen PL, Lin HJ, Wu YH, Tsai PJ, Tsai YS, Ko WC. Hung YP, et al. Among authors: tsai pj, tsai ys. PLoS One. 2012;7(11):e49102. doi: 10.1371/journal.pone.0049102. Epub 2012 Nov 7. PLoS One. 2012. PMID: 23145084 Free PMC article.

6

Risk factors of fecal toxigenic or non-toxigenic Clostridium difficile colonization: impact of Toll-like receptor polymorphisms and prior antibiotic exposure.

Hung YP, Lin HJ, Wu TC, Liu HC, Lee JC, Lee CI, Wu YH, Wan L, Tsai PJ, Ko WC. Hung YP, et al. Among authors: tsai pj. PLoS One. 2013 Jul 25;8(7):e69577. doi: 10.1371/journal.pone.0069577. Print 2013. PLoS One. 2013. PMID: 23936050 Free PMC article.

7

Risk factors for Clostridium difficile-associated diarrhea among hospitalized adults with fecal toxigenic C. difficile colonization.

Lin HJ, Hung YP, Liu HC, Lee JC, Lee CI, Wu YH, Tsai PJ, Ko WC. Lin HJ, et al. Among authors: tsai pj. J Microbiol Immunol Infect. 2015 Apr;48(2):183-9. doi: 10.1016/j.jmii.2013.08.003. Epub 2013 Sep 21. J Microbiol Immunol Infect. 2015. PMID: 24064285 Free article.

8

Clinical impact of Clostridium difficile colonization.

Hung YP, Lee JC, Lin HJ, Liu HC, Wu YH, Tsai PJ, Ko WC. Hung YP, et al. Among authors: tsai pj. J Microbiol Immunol Infect. 2015 Jun;48(3):241-8. doi: 10.1016/j.jmii.2014.04.011. Epub 2014 Jun 2. J Microbiol Immunol Infect. 2015. PMID: 24890755 Free article. Review.

9

Clostridium difficile ribotype 126 in southern Taiwan: a cluster of three symptomatic cases.

Hung YP, Lin HJ, Tsai BY, Liu HC, Liu HC, Lee JC, Wu YH, Wilcox MH, Fawley WN, Hsueh PR, Tsai PJ, Ko WC. Hung YP, et al. Among authors: tsai pj, tsai by. Anaerobe. 2014 Dec;30:188-92. doi: 10.1016/j.anaerobe.2014.06.005. Epub 2014 Jun 21. Anaerobe. 2014. PMID: 24956433

10

Vancomycin-resistant Clostridium innocuum bacteremia following oral vancomycin for Clostridium difficile infection.

Hung YP, Lin HJ, Wu CJ, Chen PL, Lee JC, Liu HC, Wu YH, Yeh FH, Tsai PJ, Ko WC. Hung YP, et al. Among authors: tsai pj. Anaerobe. 2014 Dec;30:24-6. doi: 10.1016/j.anaerobe.2014.07.009. Epub 2014 Aug 5. Anaerobe. 2014. PMID: 25102472

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

430 results

Search Page